Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-679-0 | CAS number: 98-54-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.071 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Derivation of DNELs
For the derivation of the DNELs two different studies considering different endpoints can be used. Two studies were assigned relevant key studies reflecting repeated exposure. A 2-generation study in rats was qualified as subchronic study with a dose descriptor chosen to be the NOAEL of 70 mg/kg/day to address systemic toxicity.
The 2nd approach is used to consider the potential depigmentation effects (vitiligo) of ptBP. In a 6-month oral toxicity study in mice to address skin depigmentation, a LOAEL of 103 mg/kg/day was observed.
Modification of dose descriptor
In order to adjust the NOAEL for the other/relevant exposures, a modification has to be made for workers and the general public. Factors have to be applied to adjust for human respiratory conditions as well as duration of exposure.
All factors used in the calculation have been suggested in the technical guidance document for the derivation of DNELs (Chapter R8).
Two-generation reproduction toxicity in rats
Oral NOAEL = 70 mg/kg/d
Factor for standard respiratory volume rat: 1/0.38 m3/kg/d
Factor for standard respiratory volume man and 8-h exposure: 6.7 m3 (8h) / 10 m3 (8h)
Corrected NOAEC: 123 mg/ m3
Mouse depigmentation study
Oral LOAEL = 103 mg/kg/d
Factor for standard respiratory volume rat: 1/0.38 m3/kg/d
Factor for standard respiratory volume man and 8 -h exposure: 6.7 m3 (8h) / 10 m3 (8h)
Corrected NOAEC: 182 mg/ m3
Additional assessment factors to account for inter- and intraspecies differences, exposure duration, etc. have to be considered.
Starting point - rat multigeneration study:
-worker, dermal exposure: AF = 100 (10 for interspecies/allometric scaling and 5 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure)
-worker inhalation exposure: AF = 25 (2.5 for interspecies and 5 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure)
starting point - mouse depigmentation study:
-worker, dermal exposure: AF = 525 (17.5 for interspecies/allometric scaling and 5 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure, 3 since starting point is LOAEL)
-worker inhalation exposure: AF = 75 (2.5 for interspecies and 5 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure, 3 since starting point is LOAEL)
Summary DNELs
DNELs based on - two-generation reproduction toxicity in rats:
Oral route
oral NOAEL = 70 mg/kg/d
AF = 100
DNELoral = 0.7 mg/kg
Inhalation route / systemic exposure
Corrected NOAEC = 123 mg/m3
AF = 25
DNELinhal = 4.9 mg/m3
Dermal route/systemic exposure: No oral DNEL need to be derived for workers. However, in the absence of dermal data, the dermal route is covered by oral route information.
DNELs based on - mouse depigmentation study:
Oral Route
Oral LOAEL = 103 mg/kg/d
AF = 525
DNELoral = 0.2 mg/kg
Inhalation route / systemic exposure
Corrected LOAEC = 182 mg/m3
AF = 75
DNELinhal = 2.4 mg/m3
DNEL derivation starting from available OEL value
Dermal route/systemic exposure
ptBP is absorbed via the respiratory tract and through intact skin in workers exposed occupationally. Several human studies are available. However, these studies are of low quality and are therefore not suitable in risk characterization.
In a Japanese plant no new cases of skin depigmentation arose after improvement of the working conditions yielding an average excretion of ptBP in urine of about 2 mg ptBP/l urine in the highest exposed workers who were exposed both by inhalation and through skin contact. The German biological limit value (BAT-value) in urine is based on this study. This value corresponds to a working place exposure of 0.5 mg/m3, which was in consequence proposed as preliminary MAK-value by the German MAK Commission [4].
For worker exposure via the dermal and inhalative route, the MAK-value can be used as the base for the respective DNELs. In comparison to the DNEL calculations based on the selected mouse study, the MAK value represents the more stringent course of risk assessment. The MAK value considers both significant dermal and systemic exposure.
Since no data on absorption for the different routes of exposure are available, the assumption has to be made that no difference in exposure exists. Consequently, the DNELs for long-term exposure via the dermal and oral route are the same.
Acute DNELs: Worker: according to the REACh "Guidance on information requirements and chemical safety assessment, Part B: Hazard Assessment", above 10 t/y, the establishment of acute toxicity DNEL is unnecessary in most cases, as the DNEL based on repeated dose toxicity is normally sufficient to ensure that adverse effects do not occur. DNEL for acute/short-term exposure-local effects was not quantifiable; however, ptBP is reported to be highly irritating to skin, eyes and respiratory tract; therefore, effect must be assessed qualitatively. Thus, as long term DNELs are available for ptBP, separate acute DNELs were not derived.
Long-term DNELs: German MAK value: 0.5 mg/m3, based on occupational exposure of 8 hours/day, 5 days/week; (Reference: Deutsche Forschungsgemeinschaft List of MAK and BAT Values 2007 Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area Report No. 43)
Modified concentration for DNEL Calculation
Worker/Inhalation = 0.5 mg/m3 (no adjustment required)
Worker/Dermal =0.5 mg/m3 x 10 m3/d/70 kg = 0.071 mg/kg/d (no adjustment for absorption)
Assessment Factors: no adjustments required for interspecies, exposure duration, dose response or quality of whole database as DNEL is based on an occupational limit for workers.
Final DNELs
Worker/Inhalation DNEL = 0.5 mg/m3
Worker/dermal DNEL =0.071 mg/kg/d
Absorption Data
Based on the physicochemical properties of ptBP alone [i.e., low molecular weight (150.22 g/mol), low Kow value (3.29), and high water solubility (610 mg/L)], the absorption of ptBP from various routes of exposure is expected to be 100%.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.09 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 2
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.026 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 2
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.026 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 2
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- acute toxicity
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Derivation of DNELs For the derivation of the DNELs two different studies considering different endpoints can be used. Two studies were assigned relevant key studies reflecting repeated exposure. A 2-generation study in rats was qualified as subchronic study with a dose descriptor chosen to be the NOAEL of 70 mg/kg/day to address systemic toxicity. The 2nd approach is used to consider the potential depigmentation effects (vitiligo) of ptBP. In a 6-month oral toxicity study in mice to address skin depigmentation, a LOAEL of 103 mg/kg/day was observed. Modification of dose descriptor In order to adjust the NOAEL for the other/relevant exposures, a modification has to be made for workers and the general public. Factors have to be applied to adjust for human respiratory conditions as well as duration of exposure. All factors used in the calculation have been suggested in the technical guidance document for the derivation of DNELs (Chapter R8). Two-generation reproduction toxicity in rats Oral NOAEL = 70 mg/kg/d Factor for standard respiratory volume rat: 1/1.15 m3/kg/d Corrected NOAEC: 61 mg/ m3 Mouse depigmentation study Oral LOAEL = 103 mg/kg/d Factor for standard respiratory volume rat: 1/1.15 m3/kg/d Corrected NOAEC: 90 mg/ m3 Additional assessment factors to account for inter- and intraspecies differences, exposure duration, etc. have to be considered. Starting point: rat multigeneration study - General population/dermal exposure: AF = 200 (10 for interspecies/allometric scaling and 10 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure) - General population/inhalation exposure: AF = 50 (2.5 for interspecies and 10 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure) starting point: mouse depigmentation study - General population/dermal exposure: AF = 1050 (17.5 for interspecies/allometric scaling and 10 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure, 3 since starting point is LOAEL) - General population/inhalation exposure: AF = 150 (2.5 for interspecies and 10 for intraspecies differences, 2 for extrapolation from subchronic to chronic exposure, 3 since starting point is LOAEL) Summary DNELs DNELs based on two-generation reproduction toxicity in rats. Oral route oral NOAEL = 70 mg/kg/d AF = 200 DNELoral = 0.35 mg/kg Inhalation route / systemic exposure Corrected NOAEC = 61 mg/m3 AF = 50 DNELinhal = 1.2 mg/m3 DNELs based on mouse depigmentation study. Oral Route Oral LOAEL = 103 mg/kg/d AF = 1050 DNELoral = 0.1 mg/kg Inhalation route / systemic exposure Corrected LOAEC = 90 mg/m3 AF = 150 DNELinhal = 0.6 mg/m3 DNEL derivation starting from available OEL value Dermal route/systemic exposure ptBP is absorbed via the respiratory tract and through intact skin in workers exposed occupationally. Several human studies are available. However, these studies are of low quality and are therefore not suitable in risk characterization. In a Japanese plant no new cases of skin depigmentation arose after improvement of the working conditions yielding an average excretion of ptBP in urine of about 2 mg ptBP/l urine in the highest exposed workers who were exposed both by inhalation and through skin contact. The German biological limit value (BAT-value) in urine is based on this study. This value corresponds to a working place exposure of 0.5 mg/m3, which was in consequence proposed as preliminary MAK-value by the German MAK Commission [4]. Since no data on absorption for the different routes of exposure are available, the assumption has to be made that no difference in exposure exists. Consequently, the DNELs for long-term exposure via the dermal and oral route are the same. Acute DNELs - General Population: Similar to above for worker, assessment of acute systemic effects should default to the long term systemic DNELs; ptBP is reported to be highly irritating to skin and eyes, however, effect must be assessed qualitatively. Long-term DNELs: The long-term DNEL for the general population was derived from the worker MAK. Starting Dose for DNEL calculation: 0.5 mg/m3 (based on occupational exposure of 8 hours/day, 5 days/week; need to be corrected to account for different respiratory volume and exposure frequency & duration Modified dose for DNEL Calculation General Population/Inhalation = 0.5 mg/m3x10/6.7 x 8/24 x 5/7 = 0.18 mg/m3 General Population/Oral = 0.18 mg/m3 x 20 m3/d/70 kg = 0.0514 mg/kg/d (no adjustment for absorption) General Population /Dermal = 0.18 mg/m3 x 20 m3/d/70 kg = 0.0514 mg/kg/d (no adjustment for absorption) Assessment Factors (AF): No adjustments required for interspecies, exposure duration, dose response or quality of whole database as DNEL is based on an occupational limit for workers. An AF of 2 is applied for differences between workers and general population (basis: when extrapolating from animal to human, the recommended AF is 10 for general population and 5 for worker. Since the starting dose is corrected for continuous exposure, an additional 2 fold AF for differences was considered sufficient) Final DNELs General population/dermal DNEL = 0.0514mg/kg/d/2 = 0.026 mg/kg/d; General population/Inhalation DNEL 0.18 mg/m3/2 = 0.09 mg/m3; General population/oral DNEL = 0.0514mg/kg/d/2 = 0.026 mg/kg/d Absorption Data Based on the physicochemical properties of ptBP alone [i.e., low molecular weight (150.22 g/mol), low Kow value (3.29), and high water solubility (610 mg/L)], the absorption of ptBP from various routes of exposure is expected to be 100%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
